Profil
Harry Råstedt is currently working as a Director at Abera Bioscience AB since 2024.
Previously, he worked as the Head-Vaccines at GlaxoSmithKline AB and as the Vice President & General Manager at GSK Vaccines GmbH.
Postes actifs de Harry Råstedt
| Sociétés | Poste | Début |
|---|---|---|
| ABERA BIOSCIENCE AB | Directeur/Membre du Conseil | 12/06/2024 |
Anciens postes connus de Harry Råstedt
| Sociétés | Poste | Fin |
|---|---|---|
GlaxoSmithkline AB
GlaxoSmithkline AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
GSK Vaccines GmbH
GSK Vaccines GmbH Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
GlaxoSmithkline AB
GlaxoSmithkline AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
GSK Vaccines GmbH
GSK Vaccines GmbH Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Abera Bioscience AB
Abera Bioscience AB BiotechnologyHealth Technology Operates as biotechnology company that develops bacterial-based platforms for delivery of vaccines and drugs | Health Technology |
















